AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 291: R115-R123, 2006. First published February 16, 2006; doi:10.1152/ajpregu.00002.2006
0363-6119/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/1/R115    most recent
00002.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayes, M. R.
Right arrow Articles by Covasa, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayes, M. R.
Right arrow Articles by Covasa, M.

APPETITE, OBESITY, DIGESTION, AND METABOLISM

Serotonin type-3 receptors mediate cholecystokinin-induced satiation through gastric distension

Matthew R. Hayes, Fiona M. Chory, Claire A. Gallagher, and Mihai Covasa

Department of Nutritional Sciences, College of Health and Human Development, The Pennsylvania State University, University Park, Pennsylvania

Submitted 4 January 2006 ; accepted in final form 9 February 2006


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
We have previously shown that serotonin type-3 (5-HT3) receptors mediate cholecystokinin (CCK)-induced satiation and that this effect is dependent on postoropharyngeal feedback. However, the independent contributions of gastric and intestinal feedback in 5-HT3 receptor mediation of suppression of food intake by CCK have not been determined. Using a sham-feeding preparation combined with intraduodenal sucrose infusion, we show that blockade of 5-HT3 receptors by ondansetron (1 mg/kg ip) had no effect on suppression of sham feeding by intraduodenal 15% sucrose infusion (4 ml/10 min), CCK (2 µg/kg ip) administration, or the combination of the two treatments. In separate experiments consisting of either sham-feeding rats that received gastric distension with the use of a balloon or real-feeding rats whose stomachs were distended using gastric loads of saline after the occlusion of the pylorus, we tested the hypothesis that gastric feedback signals are necessary for activation of 5-HT3 receptors. Ondansetron significantly attenuated suppression of sham sucrose intake after a 10-ml gastric balloon distension (30.5 ± 2.2 vs. 20.2 ± 2.2 ml, respectively) and gastric distension combined with CCK (21.9 ± 1.4 vs. 12.0 ± 1.7 ml, respectively). When intestinal feedback was eliminated in a real-feeding paradigm by closing the pylorus using a cuff preparation, ondansetron attenuated suppression of sucrose intake produced by a 10-ml saline gastric load (6.8 ± 0.7 vs. 4.2 ± 0.4 ml, respectively). Finally, when CCK (1 µg/kg) was administered in combination with a 5-ml saline gastric load in a real-feeding preparation, ondansetron significantly attenuated suppression of sucrose intake by CCK (9.0 ± 0.9 vs. 6.3 ± 0.5 ml, respectively), as well as the enhanced suppression of intake by CCK plus gastric load (6.9 ± 0.6 vs. 4.6 ± 0.5 ml, respectively). These findings demonstrate that CCK-induced activation of 5-HT3 receptors requires gastric, but not intestinal feedback.

food intake; stomach; synergistic

WITHIN-MEAL CONTROL OF FOOD intake has been postulated to occur in response to neuronal integration of stomach and intestinal feedback signals (42, 46, 52). Anorectic signals originating from the stomach occur almost exclusively in response to volumetric distension of the organ (41, 42), whereas intestinal anorectic signals originate largely in response to the nutrient and chemical properties of a meal (17, 46, 60). A considerable amount of work has examined the mechanisms by which the presence of nutrients within the small intestine results in satiation for food. The majority of this evidence agrees that intraintestinal nutrients reduce food intake largely through vagal afferent signaling resulting from neuronal activation via paracrine and/or endocrine products of intestinal origin (for a review see Ref. 46). In addition to directly signaling for satiation, these intestinally derived gut peptides and neurotransmitters stimulate vagovagal reflexes and reduce the rate of gastric emptying, which ultimately results in retention of stomach contents (34, 36, 37). Although it is known that gastric signals of satiation are primarily mediated along the gastric and hepatic branches of the vagus (40), as well as splanchnic afferents (54), little work has been done to identify the mechanisms and neuronal substrates responsible for mediating these signals.

Whereas the neuronal substrate(s) responsible for mediating gastric satiation signals by and large have remained unidentified, considerable attention has been devoted to the intestinally derived satiety signal cholecystokinin (CCK) for both its ability to inhibit gastric emptying (21, 35, 37) and to potentiate gastric distension satiation signaling (26, 37, 51). However, CCK-induced enhancement of satiation signaling is not limited exclusively to its interaction with gastric distension. In fact, CCK-induced activation of CCK-1 receptors has been shown to enhance both suppression of food intake and neuronal signaling when simultaneously combined with other anorectic signals including, but not limited to intraduodenal nutrients (9, 59), amylin (2, 31), leptin (1, 32), bombesin (57), and serotonin (5-HT) (6, 7, 19). Despite the fact that activation of CCK-1 receptors is critical for the aforementioned interactions in control of food intake, CCK-1 receptors themselves do not often directly mediate noncholecystokinergic neuronal signaling, such as those derived from gastric distension (55, 57). Therefore, the interaction between CCK and gastric distension in suppression of food intake likely involves participation of other satiating neuronal signals. 5-HT is one likely candidate, because it is released in response to gastric distension (33) and synergistically suppresses food intake when systemically combined with CCK (19). However, participation of the serotonergic system in mediating gastric distension-induced suppression of food intake has not been tested.

CCK and 5-HT are released in close proximity from gastrointestinal endocrine cells in response to various stimuli, such as gastric distension (5-HT; Ref. 33) and the presence of nutrients within the small intestine (both CCK and 5-HT; Refs. 29, 46, 47). The physiological actions of CCK, including satiation (46, 47) and suppression of gastric emptying (45), are largely mediated by vagal sensory nerve fibers. Likewise, activation of vagal sensory nerve fibers occurs when 5-HT is endogenously released in response to gastrointestinal stimulation (33, 44). Whereas cholecystokinergic or serotonergic excitation of peripheral sensory nerve fibers independently reduces meal size, reports have also shown that these two systems work together in control of food intake and various neural modulatory functions (6, 19, 30). Indeed, our laboratory has recently shown that simultaneous systemic administration of CCK and 5-HT synergistically suppress intake (19), further supporting the notion of cooperation between CCK and 5-HT in the overall control of food intake.

Of the seven distinct classes of 5-HT receptor types identified, a number of these have been implicated in mediation of CCK-induced satiation. Specifically, we (21, 22) and others (11) have previously shown that administration of ondansetron, a selective 5-HT type-3 (5-HT3) receptor antagonist, attenuates suppression of intake resulting from systemic CCK administration. Likewise, 5-HT3 receptors have been shown to mediate both intestinal nutrient- and CCK-induced inhibition of gastric emptying (21, 44). Recently, however, we reported that ondansetron was unable to alter CCK-induced suppression of sham feeding (21). This finding indicates that gastric/postgastric feedback is necessary for 5-HT3 receptor mediation of CCK-induced satiation; however, the underlying physiological mechanisms are still unclear.

Previous reports have shown that when CCK is administered in combination with gastric distension, an enhanced suppression of food intake is observed (26, 37, 51). Likewise, CCK and gastric distension have been shown to mutually amplify stimulation of vagal afferent fibers (50), as well as enhance neuronal activation of the dorsal hindbrain (55). Whereas these previous findings show CCK-induced retention of stomach contents enhances CCK's satiating signal via gastric distension, the specific neuronal substrates responsible for mediating gastric distension's satiating signals have not been completely elucidated. Mazda et al. (33) suggested that gastric distension induces activation of 5-HT3 receptors by releasing endogenous 5-HT. Therefore, we hypothesize that the enhancement of CCK-induced satiation by gastric distension involves 5-HT3 receptor activation. This is supported by our previous findings showing that in the absence of postoropharyngeal feedback, 5-HT3 receptors do not mediate CCK-induced satiation (21). No studies, however, have addressed the specific contributions of gastric vs. postgastric feedback participation in this effect.

Therefore, by using a sham-feeding preparation combined with intestinal nutrient infusion we first tested the hypothesis that gastric feedback signals are necessary for participation of 5-HT3 receptors in suppression of food intake by CCK. Blockade of 5-HT3 receptors had no effect on suppression of sham feeding by CCK, nutrient infusion, or CCK plus nutrient infusion combination. In the next study, we occluded the pylorus by using an inflatable cuff and examined the independent contribution of 5-HT3 receptors in mediating suppression of intake by gastric distension in a real-feeding paradigm and in the absence of intestinal feedback. This preparation enabled us to examine 5-HT3 receptor mediation of gastric distension-induced satiation when the volume of distension and the rate of stomach fill were either controlled by the rate and duration of ingestion or were experimentally manipulated via gavaged gastric loads. We report that 5-HT3 receptors mediate suppression of food intake by gastric distension in the absence of intestinal negative feedback.

To assess participation of 5-HT3 receptors in suppression of food intake by gastric distension when combined with CCK, in the next two studies, we measured sham and real feeding of ondansetron-pretreated rats after stomach distension via balloon inflation or gastric preloads. Blockade of 5-HT3 receptors attenuated suppression of sham feeding by balloon distension and by CCK combined with balloon distension. Furthermore, we found that ondansetron treatment attenuated suppression of real feeding after concomitant administration of CCK and gastric preloads.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Animals and Drugs

Adult (250–350 g) male Sprague-Dawley rats (Harlan, Indianapolis, IN) were individually housed (wire hanging cages) in a temperature- and light-controlled environment with a 12:12-h light-dark cycle (lights off at 1800). Rats were provided ad libitum access to standard rat chow (Purina 5001) and water, except as indicated in the experimental procedure when they were deprived of food but not water overnight (16 h). Before testing, animals were adapted to experimental conditions for 1 wk. This protocol was approved by The Pennsylvania State University Institutional Animal Care and Use Committee.

The drugs used in these experiments were CCK octapeptide sulfate (CCK-8; American Peptide, Sunnyvale, CA) and ondansetron HCl (a gift from GlaxoSmithKline, Barnard Castle, UK), a selective 5-HT3 receptor antagonist. All drugs were dissolved in sterile 0.9% saline and were administered via an intraperitoneal injection in a volume of 1.0 ml/kg body wt. The CCK doses (1.0 and 2.0 µg/kg) were chosen on the basis of numerous CCK dose-response studies demonstrating reliable and replicable suppression of both real and sham feeding (8, 21, 22). For sham feeding, CCK was administered at a dose of 2.0 µg/kg to produce a percent suppression in sham feeding comparable to that seen in real feeding by CCK as previously described (21). On the basis of our laboratory's previous dose-response experiments examining 5-HT3 receptor mediation of intestinal nutrient- (48) and CCK-induced (19, 22) satiation, the dose of 1.0 mg/kg of ondansetron was chosen in the current studies because of its ability to effectively attenuate suppression of real feeding by these two stimuli, with higher doses producing no greater effect (19, 48).

Surgical Procedures

Gastric cannulation. Rats used in sham-feeding studies were implanted with stainless steel gastric cannulas according to a modification of the procedure previously described by Yox and Ritter (60). Briefly, the animals were anesthetized with a xylazine/ketamine/AcePromazine cocktail and the flanged end of a stainless steel gastric cannula (13 mm long, 6 mm ID, 8 mm OD) was inserted through the ventral wall of the nonglandular portion of the stomach (corpus) near the greater curvature. The cannula was secured with a purse-string suture, a piece of Marlex mesh was placed around it to help prevent leaking, and the nonflanged end of the cannula was externalized through an incision in the left paramedian abdominal wall. The cannula was kept closed with a stainless steel screw except during experiments. A minimum of 10 days was allowed for recovery from surgery.

Intestinal cannulation. Rats used in intraintestinal infusion studies were also fitted with chronic duodenal catheters while anesthetized for gastric cannulation surgery as described previously by Yox and Ritter (60). Each duodenal catheter consisted of a 22-cm length of silicone rubber tubing (0.025 in. ID, 0.047 in. OD; Dow Corning, Midland, MI). Briefly, catheters were inserted 2 cm distal to the pylorus and advanced 6 cm within the duodenal lumen in an aborad direction. The exposed end of the catheter exited through a skin incision over the dorsal aspect of the cranial portion of the neck and was occluded with a stainless steel wire (obturator), which was removed only for flushing of the catheter and intestinal infusions. A minimum of 10 days was allowed for recovery during which rats attained their preoperative body weights before the start of testing.

Pyloric cuff. Pyloric cuffs were constructed and surgically implanted according to previously described methods (10, 58). Briefly, the cuffs consisted of Silastic sheeting (0.005 in. thick) cut into 0.6-mm x 4-cm strips. At one end of each strip, a 20-cm length of Silastic tubing (0.03 in. ID, 0.056 in. OD) was affixed with silicone adhesive (Dow-Corning). Half of the length of each strip was glued flat, whereas the margins of the remaining half were joined to form a watertight pouch. This enabled only one-half of the resulting cuff to inflate and deflate (58). Rats were deeply anesthetized, and their stomachs were exteriorized via a midline celiotomy. A cuff was passed around the pyloric portion of the stomachs, and the two free ends of the cuff were joined with sutures to form a loose ring. Care was taken to avoid entrapping nerves or blood vessels in the ring. The inflatable half of the cuff was positioned along the ventral aspect of the pylorus. The cuff was then inflated with 0.6 ml of water to verify its integrity and proper positioning. Finally, the Silastic tubing was inserted through an incision in the muscles of the abdominal wall and tunneled subcutaneously to emerge at the dorsal aspect of the neck. The rats were allowed to recover from surgery for 7 days before testing began.

After completion of the experiment, the effectiveness of each cuff was assessed by measuring blood glucose levels after an oral glucose tolerance test (52) with the cuff inflated and deflated as described in our previously published work (10). If blood glucose values for a given rat were the same or higher when the cuff was inflated than when it was deflated, we assumed that the glucose solution had escaped through the inflated cuff into the duodenum, and data obtained from that animal were discarded. In addition, cuff placement and patency was also determined in a postmortem examination as previously described (10). Each rat's cuff was inflated with 0.6 ml of water, followed by a 10-ml gavage of a dye solution. Each rat was then immediately euthanized via CO2 asphyxiation, and its stomach, pyloric cuff, and proximal duodenum were exteriorized via midline celiotomy. A hemostat was applied to the cardiac portion of the stomach. A 2-cm segment of the duodenum, immediately distal to the cuff, was resected, opened, and blotted (mucosa side down) on a piece of filter paper. If dye was visible on the filter paper after the blotting, data for that animal were discarded.

Experiment 1: 5-HT3 Receptor Blockade on Inhibition of Sham Feeding by CCK Combined with Intestinal Sucrose Infusion

After recovery from surgery, rats (n = 8) equipped with chronic gastric and intestinal cannulas were trained to sham feed a 15% (wt/vol) sucrose solution after an overnight fast. During both training and testing days at 0900, rats were removed from their cages, the stainless steel screw was removed from the gastric cannula, and their stomachs were gently lavaged with warm tap water (37°C). After a drainage tube was attached to the open cannula and drugs were administered, the rats were placed in Plexiglas sham-feeding boxes as previously described by Yox and Ritter (60). Training was considered complete when sham baseline intakes were consistent and did not vary more than 8–10%, which was achieved after ~4–5 sucrose exposures. During testing, intraperitoneal drug administration consisted of either NaCl, ondansetron (1.0 mg/kg), CCK (2.0 µg/kg), or a combined injection of CCK (2.0 µg/kg) and ondansetron (1.0 mg/kg). Five minutes after injection, intestinal infusion of either 0.9% NaCl or 15% sucrose solution begun at a rate of 0.4 ml/min for 10 min. This infusion rate has been shown to be within the physiological range of gastric emptying (24). Simultaneous with the start of intestinal infusion, rats were presented with a calibrated glass burette filled with 15% sucrose solution and sham intake was recorded every 5 min for the ensuing 30 min. Each injection/infusion treatment was separated by a minimum of 48 h and was bracketed by a control NaCl/NaCl condition. A minimum of two repetitions for each injection/infusion combination was conducted for each experiment.

Experiment 2: 5-HT3 Receptor Mediation of Gastric Distension-Induced Suppression of Real Feeding After Occlusion of the Pylorus

Beginning on postoperative day 2, rats (n = 10) implanted with pyloric cuffs were habituated to cuff manipulations by inflating the cuff with increasing volumes of water (up to 0.6 ml), as well as receiving gavage loads. In addition, rats were familiarized to 15% sucrose solution for 7 days, beginning 1 wk after surgery and ending just before the start of experimental testing. Sucrose training consisted of an overnight fast (16 h) followed at 0900 by cuff manipulation, sham gavage load, and subsequent presentation of 15% sucrose solution for 30 min. For both sucrose training and experimental testing, rats were tested every other day, including weekends. On nontesting days, the rats were handled and pyloric cuffs were inflated and deflated so that the rats would be less likely to associate sensations resulting from cuff manipulations with the presentation of food.

On test days at 0900, overnight-food-deprived (16 h) rats received an intraperitoneal injection of either saline or ondansetron (1.0 mg/kg) with their cuffs either open (deflated) or closed (inflated). Five minutes after drug administration, rats received either a 5- or 10-ml load of 0.9% (wt/vol) NaCl instilled into the stomach with a syringe by hand over a period of 1 min via an orally inserted 8-Fr polythylene intragastric tube, or the inserted tube without gastric load (sham load). Immediately after gastric/sham load, rats were returned to their home cage and were presented with a calibrated glass burette filled with 15% sucrose (wt/vol) solution. Intakes were recorded to the nearest 0.1 ml at baseline and every 5 min for 30 min. Each drug/cuff/gastric load treatment was separated by a minimum of 48 h and bracketed by a control condition (NaCl injection/open cuff/sham load), with all rats receiving the same drug/cuff/gastric load treatment on the same day. Rats were tested at least twice under each experimental condition. The following six drug injection/gastric load conditions were tested with the cuff either open or closed for a total of 12 experimental conditions: saline/sham, ondansetron/sham, saline/5-ml load, ondansetron/5-ml load, saline/10-ml load, ondansetron/10-ml load.

Experiment 3: 5-HT3 Receptor Blockade on Inhibition of Sham Feeding by CCK Combined with Gastric Distension

A separate group of rats (n = 6) equipped with chronic gastric cannulas were trained to sham feed a 15% (wt/vol) sucrose solution. After overnight food deprivation, rats were removed from their cages at 0900, the stainless steel screw was removed from the gastric cannula, and their stomachs were gently lavaged with warm tap water (37°C). After a drainage tube was attached to the open cannula and drugs were administered, the rats were placed in Plexiglas sham-feeding boxes. Intraperitoneal drug administration consisted of saline, ondansetron (1.0 mg/kg), CCK (2.0 µg/kg), or a combined injection of CCK (2.0 µg/kg) and ondansetron (1.0 mg/kg). Five minutes after injection and immediately preceding presentation of sucrose, an 8-Fr Foley catheter (Bardex; Bard, Covington, GA) with an inflatable tip was fed through a drainage tube attached to the gastric fistula and advanced 0.5–0.7 cm into the lumen of the stomach. The catheter was held in place by a rubber band attached to the external end, which prevented movement from its original insertion position. The catheter was inflated with either 5 or 10 ml warmed 0.9% NaCl for a period of 10 min (13). Immediately after catheter inflation, rats were presented with a calibrated glass burette filled with 15% sucrose solution (wt/vol) and intake was recorded to the nearest 0.1 ml every 5 min for the ensuing 30 min. After the catheter was deflated (10 min into sham feeding) and removed from the stomach, rats were allowed to sham feed sucrose for the remaining 20 min. Each drug/distension treatment was given for at least two experimental days, separated by a minimum of 48 h, and was bracketed by a NaCl/no-distension condition. In all sham-feeding tests, gastric drainage was collected in plastic graduated cylinders placed beneath the cages, and the volume was recorded at experiment termination. In the event that the volume of fluid ingested was greater than the volume of gastric drainage or if gastric drainage did not occur within 15 s of the start of sham feeding, the data from that subject were discarded on the basis that the gastric fistula was not functioning properly (60).

Experiment 4: 5-HT3 Receptor Blockade on Inhibition of Real Feeding by CCK Combined with an Intragastric Preload

A separate group of overnight-fasted rats (n = 10) received an intraperitoneal injection containing either 0.9% NaCl, ondansetron (1.0 mg/kg), CCK (1.0 µg/kg), or a single combined injection of ondansetron and CCK. Five minutes after drug administration, rats received either a 5-ml load of 0.9% NaCl (wt/vol) instilled into the stomach via an orally inserted 8-Fr polythylene intragastric tube, or the inserted tube without gastric load (sham load). A 5-ml volume was used to induce stomach distension before ingested sucrose. Immediately after gastric/sham load, rats were returned to their home cage and were presented with a calibrated glass burette filled with 15% sucrose (wt/vol) solution. Intakes were recorded to the nearest 0.1 ml every 5 min for 30 min. Each drug/gastric load treatment was separated by a minimum of 48 h and bracketed by a control condition (saline injection/sham load). Rats were tested at least twice under each condition, with all rats receiving the same drug/gastric load treatment on the same day. These methods are similar in design to those reported by Moran and McHugh (37) in monkeys, with the exception that we have chosen to gavage the animals and not surgically implant a gastric catheter.

Data and Statistical Analyses

Data for each respective study were analyzed separately and expressed as means ± SE. For experiments 1, 3, and 4, sucrose intakes for all time points were analyzed by two-way repeated-measures ANOVA (rmANOVA), with drug injection and gastric/intestinal treatments as the main variables. For experiment 2, sucrose intakes were analyzed by three-way rmANOVA, with drug injection (NaCl, CCK, ondansetron), gastric load volume (0, 5, 10 ml) and cuff condition (open, closed) as the main variables. For all experiments, significant differences among treatment means (adjusted) were analyzed by pairwise Student's t-test for planned comparisons, with P < 0.05 considered statistically significant. All analyses were made using PC-SAS (version 8.02; SAS Institute, Cary, NC) mixed procedure.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
Experiment 1: 5-HT3 Receptor Blockade on Inhibition of Sham Feeding by CCK Combined with Intestinal Sucrose Infusion Two-way ANOVA revealed a significant main effect on sham sucrose intake at 30 min for drug treatment [F(3,165) = 20.50, P < 0.0001] and intestinal infusion [F(1,165) = 66.47, P < 0.0001]. There was no significant main effect of interaction between drug and intestinal infusion [F(3,165) = 0.57, P = 0.6346]. As Fig. 1 shows, sham intake in response to administration of CCK combined with intestinal infusion of 0.9% NaCl was significantly reduced at 30 min compared with control (26.4 ± 2.3 vs. 38.3 ± 1.0 ml; P < 0.0001). Ondansetron treatment alone did not produce any significant effect on sham intake compared with control (P > 0.05). Blockade of 5-HT3 receptors with ondansetron had no effect on CCK-induced suppression of sham intake (28.7 ± 2.3; P > 0.05). Intraintestinal 15% sucrose infusion reduced 30-min sham intake significantly compared with control (25.6 ± 3.2 vs. 38.3 ± 1.0 ml; P < 0.0001). However, ondansetron administration had no effect on intraintestinal sucrose-induced suppression of sham intake (27.8 ± 2.3; P > 0.05). When combined, CCK and intraintestinal sucrose significantly enhanced suppression of sham intake in an additive manner compared with control (18.3 ± 1.5 ml; P < 0.0001), intraintestinal sucrose alone (P = 0.0047), and CCK alone (P = 0.0005). Blockade of 5-HT3 receptors failed to attenuate the enhanced suppression of sham intake by CCK combined with intraduodenal sucrose infusion (18.7 ± 2.3; P > 0.05).


Figure 1
View larger version (13K):
[in this window]
[in a new window]
  		Fig. 1. Combined administration of cholecystokinin (CCK; 2.0 µg/kg ip) with an intraduodenal 0.9% NaCl infusion significantly reduced sucrose intake compared with control [NaCl infusion/saline (SAL) vehicle injection] in sham-feeding rats. Likewise, intraduodenal infusion of 15% sucrose significantly reduced sham intake compared with control. When combined, CCK and intraduodenal sucrose significantly enhanced suppression of sham intake compared with control or either treatment alone. Blockade of 5-HT3 receptors by ondansetron (OND; 1.0 mg/kg ip) alone did not alter 30-min sham intake compared with control. When coadministered, OND failed to attenuate suppression of sham intake by CCK, intraduodenal sucrose infusion, or the enhanced suppression in sham intake by CCK combined with sucrose infusion. Bars with different letters are significantly different from each other (P < 0.05).

 
Experiment 2: 5-HT3 Receptor Mediation of Gastric Distension-Induced Suppression of Real Feeding After Occlusion of the Pylorus Data from four rats were discarded from statistical analyses because of uncontrollable weight loss (resulting in euthanasia), development of pyloric strictures, and slipping of the cuff below the pylorus. For the remaining six rats, one-way ANOVA revealed an overall significant main effect for blood glucose over time after an oral glucose load [F(3, 72) = 14.73, P < 0.001]. Mean blood glucose for these six rats at 30 min (79.0 ± 4.2 mg/dl) and 60 min (69.8 ± 2.5 mg/dl) after occlusion of the pylorus and administration of an oral glucose load were not significantly different from each other (P > 0.05) or from blood glucose recorded just before receiving the oral glucose load (70.7 ± 3.0 mg/dl; P > 0.05). However, 30 min after the release of the pyloric cuff (90 min after oral glucose load), there was a significant rise in blood glucose (98.3 ± 3.8 mg/dl) compared with blood glucose values when the cuff was closed (P ≤ 0.004). For these rats, the cuff was assessed to be effective at preventing gastric emptying. Therefore, the experimental data collected from six of the original ten animals were statistically analyzed.

Three-way ANOVA revealed a significant main effect on 30-min sucrose intake for gastric load [F(2,54) = 5.25, P = 0.0083] and cuff condition [F(1,54) = 88.28, P < 0.0001]. There was no significant main effect of drug treatment [F(1,54) = 2.24, P > 0.1406]. Likewise, there was no significant interaction between drug and gastric load [F(5,54) = 0.95, P > 0.46] or drug and cuff condition [F(1,54) = 1.1, P = 0.2993]. However, there was an overall significant interaction between gastric load and cuff condition [F(2,54) = 7.88, P = 0.001], as well as drug, cuff condition, and gastric load [F(7,54) = 2.93, P = 0.0112]. As illustrated in Fig. 2, 30-min sucrose intake after saline injection was not significantly different, whether the cuff was in a closed (13.4 ± 0.6 ml) or open (16.1 ± 0.9 ml; P > 0.05) condition. Similarly, ondansetron alone did not produce any effect on sucrose intake whether the cuff was closed or open (P > 0.05). Administration of a 5-ml gastric NaCl load with the cuff closed significantly suppressed sucrose intake (9.1 ± 1.1 ml) compared with control (saline/cuff open/sham load; 16.1 ± 0.9 ml, P < 0.001) and intakes with the cuff closed in the absence of gastric load (saline/cuff closed/sham load; 13.4 ± 0.6 ml; P = 0.006). Instillation of a 5-ml NaCl load with the cuff open produced no significant effect on intake (15.8 ± 1.9 ml) compared with control (saline/cuff open/sham load; P > 0.05). When a 10-ml NaCl load was instilled with the cuff closed, sucrose intake was further suppressed (4.2 ± 0.4 ml) compared with control (saline/cuff open/sham load; P < 0.0001), as well as intake after a 10-ml NaCl load with the cuff open (15.3 ± 1.9 ml; P < 0.0001). Ondansetron administration significantly attenuated suppression of sucrose intake produced by a 10-ml NaCl load (6.8 ± 0.7 ml; P = 0.037), but not by a 5-ml NaCl load (9.0 ± 0.7 ml; P > 0.05) when the cuff was closed.


Figure 2
View larger version (15K):
[in this window]
[in a new window]
  		Fig. 2. Occlusion of the pylorus did not significantly suppress 30-min intake of 15% sucrose solution. Food intake was significantly suppressed with the pylorus occluded in response to a 0.9% NaCl gavage load (5 and 10 ml) in a volume-dependent fashion. Blockade of serotonin type-3 (5-HT3) receptors by OND (1.0 mg/kg ip) had no effect on suppression of intake by occlusion of the pylorus with either a sham or 5-ml NaCl gavage load. However, OND significantly attenuated the enhanced suppression of intake by a 10-ml gastric load after pyloric occlusion. Bars with different letters are significantly different from each other (P < 0.05).

 
Experiment 3: 5-HT3 Receptor Blockade on Inhibition of Sham Feeding by CCK Combined with Gastric Distension Two-way ANOVA revealed a significant main effect on sham sucrose intake at 30 min for drug treatment [F(3,54) = 38.52, P < 0.0001], gastric distension [F(2,54) = 35.98, P < 0.0001], and interaction between drug and gastric distension [F(6,54) = 3.45, P = 0.0059]. As Fig. 3 shows, sham intake in response to administration of CCK alone was reduced at 30 min compared with control (23.5 ± 3.1 vs. 40.8 ± 0.8 ml; P < 0.0001). Ondansetron treatment alone did not produce any significant effect on sham intake compared with control (40.0 ± 2.1; P > 0.05). Blockade of 5-HT3 receptors with ondansetron had no effect on CCK-induced suppression of sham intake (25.8 ± 2.9 vs. 23.5 ± 3.1 ml; P > 0.05). Gastric distension alone significantly reduced 30-min sham intake compared with control, 5 ml, and 10 ml volumes (40.8 ± 0.8, 28.2 ± 2.2, and 20.2 ± 2.2 ml, respectively; P < 0.0001). Ondansetron administration significantly attenuated 10-ml gastric distension-induced suppression of sham intake (30.5 ± 2.2 ml; P = 0.001). However, ondansetron was unable to produce a significant attenuation of intake after 5-ml gastric distension (33.6 ± 2.3 vs. 28.2 ± 2.2 ml for ondansetron + 5 ml and 5 ml alone, respectively; P > 0.05) When combined, CCK and 5-ml gastric distension enhanced suppression of intake compared with control, saline injection/sham distension condition (19.1 ± 1.7 vs. 40.8 ± 0.8 ml; P < 0.0001), and 5-ml gastric distension alone (19.1 ± 1.7 vs. 28.2 ± 2.2 ml; P = 0.003). However, when CCK was combined with 10-ml gastric distension, this produced a further suppression in sham intake (12.0 ± 1.7 ml) compared with control (saline injection/sham distension; 40.8 ± 0.8 ml; P < 0.0001), 10-ml gastric distension alone (20.2 ± 2.2 ml; P = 0.002), CCK administration alone (23.5 ± 3.1 ml; P < 0.0001), and suppression of intake by CCK combined with 5-ml gastric distension (19.1 ± 1.7 ml; P = 0.005). Blockade of 5-HT3 receptors significantly attenuated the enhanced suppression in sham intake by CCK combined with 10-ml gastric distension (21.9 ± 1.4 ml; P = 0.036), but did not significantly attenuate the enhanced suppression of intake by CCK combined with 5-ml distension (24.3 ± 1.7 ml; P > 0.05).


Figure 3
View larger version (16K):
[in this window]
[in a new window]
  		Fig. 3. Administration of CCK (2.0 µg/kg ip) significantly reduced sham 15% sucrose intake compared with control. Gastric distension significantly reduced sham intake at both 5- and 10-ml volumes of distension compared with control (sham distension). When combined, CCK enhanced both 5- and 10-ml gastric distension-induced suppression of sham sucrose intake. Blockade of 5-HT3 receptors by OND (1.0 mg/kg ip) alone did not alter 30-min sham intake compared with control. OND, when coadministered with CCK was unable to attenuate CCK-induced suppression of 30-min sham intake. However, OND significantly attenuated suppression of sham intake by 10-ml gastric distension, as well as the enhanced suppression produced by CCK when combined with 10-ml distension. Bars with different letters are significantly different from each other (P < 0.05).

 
Experiment 4: 5-HT3 Receptor Blockade on Suppression of Real Feeding by CCK Combined with Intragastric Load Two-way ANOVA revealed a significant main effect on sucrose intake at 30 min for drug treatment [F(3,62) = 48.65, P < 0.0001] and gastric load [F(1,62) = 25.65, P < 0.0001]. There was no significant main effect of interaction between drug treatment and gastric load [F(3,62) = 0.48, P > 0.05]. As illustrated in Fig. 4, systemic administration of CCK significantly reduced 30-min sucrose intake (6.3 ± 0.5 ml) compared with control (12.6 ± 0.3 ml; P < 0.0001). Ondansetron administration significantly attenuated CCK-induced suppression of real feeding (9.0 ± 0.9 vs. 6.3 ± 0.5 ml, for CCK and CCK/ondansetron, respectively; P = 0.034). Independently, 5-ml 0.9% NaCl gastric load produced a significant reduction in 30-min sucrose intake (10.9 ± 0.6 ml) compared with sham load (12.6 ± 0.3 ml; P < 0.05). Ondansetron administration alone did not produce any significant effect on sucrose intake compared with control (12.1 ± 0.5 vs. 12.6 ± 0.3 ml; P > 0.05). When CCK was combined with a 5-ml 0.9% NaCl gastric load, this resulted in an enhanced reduction of sucrose intake (4.6 ± 0.5 ml) compared with control (12.6 ± 0.3 ml; P < 0.0001) or NaCl gastric load alone (10.9 ± 0.6 ml; P < 0.0001). Blockade of 5-HT3 receptors significantly attenuated the enhanced suppression of food intake by CCK and gastric load (6.9 ± 0.6 vs. 4.6 ± 0.5 ml for CCK/ondansetron/gastric load and CCK/gastric load, respectively; P = 0.041).


Figure 4
View larger version (13K):
[in this window]
[in a new window]
  		Fig. 4. Intraperitoneal administration of CCK (1.0 µg/kg) alone significantly reduced intake of 15% sucrose compared with control (saline injection/sham gastric load). OND (1.0 mg/kg ip) alone did not alter 30-min intake compared with control. Administration of a 5-ml 0.9% NaCl load via oral gavage significantly suppressed intake compared with control (saline injection/sham gastric load). CCK administration before a 5-ml NaCl load produced an enhanced suppression in sucrose intake compared with control (saline injection/sham gastric load), CCK alone, or 5-ml NaCl gavaged load alone. OND significantly attenuated CCK-induced suppression of intake, as well as the enhanced suppression of intake produced by CCK combined with a gastric NaCl load. Bars with different letters are significantly different from each other (P < 0.05).

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
The results of these studies revealed that 5-HT3 receptor mediation of CCK-induced satiation requires gastric (i.e., filling and subsequent distension), but not intestinal feedback mechanisms. Specifically, blockade of 5-HT3 receptors had no effect on suppression of sham feeding by intraduodenal nutrients, CCK administration, or the combination of the two treatments. However, blockade of 5-HT3 receptors attenuated both suppression of sham feeding by gastric distension, as well as the enhanced suppression produced by the combination of gastric distension with CCK administration. Given our previous findings indicating that 5-HT3 receptors mediate CCK-induced satiation by delaying gastric emptying (21), current results demonstrate that CCK-induced activation of 5-HT3 receptors requires distension of the stomach. Finally, using both a sham feeding, as well as a real-feeding pyloric cuff preparation, our results demonstrate that 5-HT3 receptors mediate suppression of food intake by gastric distension in the absence of intestinal and cholecystokinergic negative feedback.

Activation of 5-HT3 receptors has been documented in numerous physiological and behavioral processes including control of gastric emptying (44), stimulation of pancreatic secretion (29), and intestinal transit (44, 62), as well as emetic (23, 28) and cardiorespiratory reflexes (5, 56). This is not surprising considering the wide anatomical distribution of 5-HT3 receptors and the fact that 5-HT is released from various cell types, including enterochromaffin cells, platelets, endothelial cells, mast cells, and serotonergic neurons (3, 16). Of particular relevance is the role of 5-HT3 receptors in physiological response controlling for food intake. For example, we have previously shown that 5-HT3 receptors mediate suppression of food intake by intestinal nutrients (48) and CCK (21, 22), as well as other physiological functions controlled by CCK, such as gastric emptying (21). Thus 5-HT3 receptors are not only critical in mediating gastric distension-induced suppression of food intake but also in the communication between the intestine and the stomach by intensifying the strength of the satiety signal. The mechanism by which this occurs is not entirely clear. However, gastric distension has been shown to cause 5-HT release (33). Therefore, these findings provide evidence that one mechanism by which ondansetron attenuates suppression of sucrose intake by gastric distension is via the release of 5-HT in response to gastric distension and subsequent blockade of 5-HT3 receptors. By combining the sham-feeding preparation with intestinal infusion of the same solution as the ingestate (15% sucrose), we were able to eliminate only gastric feedback and show that intestinal mechanisms do not contribute to 5-HT3 receptor's role in satiation by CCK. Therefore, we examined the independent participation of 5-HT3 receptors in mediating suppression of intake by gastric distension when the ingestate was confined to the stomach by using an inflatable cuff. We showed that blockade of 5-HT3 receptors attenuates suppression of real feeding by stomach distension in the absence of intestinal feedback. These findings, however, do not negate participation of 5-HT3 receptors in mediating intraintestinal nutrient-induced suppression of food intake. Indeed, we and others have shown that 5-HT3 receptors mediate suppression of food intake by both intestinal lipid (4, 49) and carbohydrate solutions (48). In view of the current data, gastric feedback is also necessary for 5-HT3 receptor mediation of suppression of real feeding by nutrients. However, direct investigation of this notion remains to be tested.

The final experiments focused on participation of 5-HT3 receptors in suppression of food intake by CCK when combined with gastric distension. We were able to demonstrate that blockade of 5-HT3 receptors attenuates the enhanced suppression of sham intake by CCK when combined with gastric balloon distension and removal of intestinal feedback by the ingestate. Finally, we showed that 5-HT3 receptors mediate the enhanced satiation produced by CCK when combined with a gastric load in a real feeding paradigm. These findings support our previous reports that 5-HT3 receptor mediation of CCK-induced satiation requires inhibition of gastric emptying (21) and show that gastric distension is required for 5-HT3 receptor mediation of CCK-induced satiation.

We observed that the most pronounced effect of ondansetron on suppression of intake by gastric distension occurred when large gastric loads (e.g., 10 ml) were used. Therefore, it appears that 5-HT3 receptors are involved in satiation primarily when stomach distension is greater, such as toward meal termination. The fact that 5-HT3 receptors participate in gastric distension-induced satiation to a greater extent when a larger volume of balloon distension was applied is supported by our sham-feeding data. Consequently, recruitment of 5-HT3 receptors in mediating CCK-induced satiation most likely occurs with a greater degree of gastric distension in response to inhibition of gastric emptying by CCK. This is supported by studies of Muurahainen et al. (38) who demonstrated that intakes of a test meal in humans were significantly lower when CCK was given after a 500-g but not a 100-g soup preload. This is not to say, however, that 5-HT3 receptors are not activated by smaller volumes of stomach distension. In fact, using an ex vivo stomach preparation, Mazda et al. (33) demonstrated that 5-HT3 receptor activation occurs with as little as 3 ml of gastric distension. Indeed, our current results show that suppression of intake by the combination of a 5-ml NaCl load with CCK administration was significantly attenuated by ondansetron. Furthermore, although not significant, our sham-feeding findings showed that blockade of 5-HT3 receptors attenuates 5-ml distension-induced suppression of sham intake. One plausible explanation for this phenomenon could be an increase in endogenous 5-HT secretion in response to an amplified stomach distension, since it is well known that enterochromaffin cells can function as gastric mechanoreceptors and release 5-HT in response to mechanical pressure (15, 61). 5-HT3 receptors are also known to mediate nausea or acute emesis (23, 28). Therefore, it could be suggested that a 10-ml distension volume could have produced nausea symptoms. However, the 5- and 10-ml volumes of distension applied in these studies are within the range of physiological distension, and well below postprandial gastric capacity and therefore are not likely noxious. Moreover, though not quantified, we did not observe any malaise-like behavior after administration of ondansetron or in response to gastric distension at any volume tested. In fact, in both real- and sham-feeding studies, rats continued to consume sucrose in response to all volumes of distension. Nonetheless, we cannot entirely rule out the possibility that there may, in fact, be some subthreshold noxious response to gastric distension activating 5-HT3 receptors.

In addition to demonstrating the involvement of 5-HT3 receptors in suppression of intake by gastric distension, the results from the pyloric cuff experiment confirmed previous findings showing that gastric fill contributes significantly to the stomach's role in satiation for food (25). In our study, however, sucrose intake was slightly reduced when the cuff was inflated and ingested fluid was confined to the stomach. Davis et al. (12) showed that occlusion of the pylorus decreases 30-min intake in rats who consume large volumes of the test meal (>15 ml) when their pylorus is open. Occlusion of the pylorus does not reduce intake in rats consuming smaller volumes of ingestate (42, 52). Given the fact that average baseline sucrose intakes in the current pyloric cuff experiment were >16 ml, our findings agree with previous reports showing a slight, but nonsignificant reduction in intake in response to occlusion of the pylorus (12).

Whereas much of the existing 5-HT3 receptor evidence points to a peripheral site of action, the effects observed in the current studies may not be attributed entirely to receptor populations in the periphery. Small amounts of ondansetron have been shown to cross the blood-brain barrier, with up to 15% of systemic ondansetron being detected in the cerebral spinal fluid (39, 53). However, the nucleus of the solitary tract and area postrema, two regions involved in the negative feedback control of food intake and densely rich in 5-HT3 receptors (14, 27, 43), exhibit circumventricular properties. Therefore, it is possible that the feeding effects observed in the present studies may also be partially due to ondansetron's ability to block hindbrain 5-HT3 receptors. We have shown that 5-HT3 receptors within the dorsal hindbrain mediate systemic CCK-induced suppression of food intake (20). Nonetheless, should systemic ondansetron act exclusively on hindbrain 5-HT3 receptors to attenuate CCK-induced satiation, hindbrain 5-HT3 receptor participation in this phenomenon would still require gastric feedback. This is supported by both previous and current sham-feeding experiments showing that in the absence of gastric feedback, systemic ondansetron is unable to attenuate CCK-induced suppression of sham feeding. Detailed studies are warranted to ascertain the potential role of hindbrain 5-HT3 receptors in mediation of CCK and gastric distension-induced suppression of food intake.

Whether ondansetron's site of action is central and/or peripheral, 5-HT3 receptor mediation of gastric distension-induced satiation appears to involve vagal excitation. Schwartz et al. (50) demonstrated that gastric distension and CCK synergistically augment gastric neural afferent activity at the level of the peripheral vagus, as measured by electrophysiological recordings. Work by Phillips and Powley (40) suggests that gastric distension-induced reductions in feeding are primarily mediated via the gastric and hepatic vagal branches, whereas the celiac branch does not play a role in this effect. In fact, Glatzle et al. (18) has shown 5-HT3 receptor expression at various locations throughout the gastrointestinal tract existing on both C-type, as well as capsaicin-resistant A-type afferents. Thus, whereas it is clear that current findings involve vagal afferent excitation, it is not entirely known whether 5-HT3 receptors mediating gastric distension-induced satiation are located on capsaicin-resistant (A-type) or capsaicin-sensitive (C-type) vagal afferent fibers.

In conclusion, the present findings indicate that 5-HT3 receptor mediation of CCK-induced satiation requires gastric, not intestinal, feedback mechanisms. Specifically, gastric distension enhances CCK-induced satiation by activating 5-HT3 receptors. In addition, these findings demonstrate that blockade of 5-HT3 receptors attenuates gastric distension-induced suppression of both real and sham feeding and that this effect occurs in response to a larger volume of stomach distension. In a broader context, since CCK-1 receptor activation occurs in response to nutrients entering the small intestine and 5-HT3 receptor activation occurs via gastric distension, it appears that CCK-1 and 5-HT3 receptors participate in inhibition of food intake by integrating both intestinal and gastric satiating signals.


   GRANTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This research was supported in part by National Institute of Neurological Disorders and Stroke Grant NS-051868.


   ACKNOWLEDGMENTS
 
The authors thank Bart De Jonghe and Carmine Di Martino for their help with these studies.


   FOOTNOTES
 

Address for reprint requests and other correspondence: M. R. Hayes, Dept. of Nutritional Sciences, College of Health and Human Development, The Pennsylvania State Univ., 126 S. Henderson, Univ. Park, PA, 16802 (e-mail: mrh212{at}psu.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Barrachina MD, Martinez V, Wang L, Wei JY, and Tache Y. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proc Natl Acad Sci USA 94: 10455–10460, 1997.[Abstract/Free Full Text]
  2. Bhavsar S, Watkins J, and Young A. Synergy between amylin and cholecystokinin for inhibition of food intake in mice. Physiol Behav 64: 557–561, 1998.[CrossRef][Medline]
  3. Bueno L, Fioramonti J, and Garcia-Villar R. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications. III. Visceral afferent pathways: a source of new therapeutic targets for abdominal pain. Am J Physiol Gastrointest Liver Physiol 278: G670–G676, 2000.[Abstract/Free Full Text]
  4. Burton-Freeman B, Gietzen DW, and Schneeman BO. Cholecystokinin and serotonin receptors in the regulation of fat-induced satiety in rats. Am J Physiol Regul Integr Comp Physiol 276: R429–R434, 1999.[Abstract/Free Full Text]
  5. Comet MA, Sevoz-Couche C, Hanoun N, Hamon M, and Laguzzi R. 5-HT-mediated inhibition of the cardiovagal baroreceptor reflex response during the defense reaction in the rat. Am J Physiol Heart Circ Physiol 287: H1641–H1649, 2004.[Abstract/Free Full Text]
  6. Cooper SJ. Cholecystokinin modulation of serotonergic control of feeding behavior. Ann NY Acad Sci 780: 213–222, 1996.[ISI][Medline]
  7. Cooper SJ, Dourish CT, and Clifton PG. CCK antagonists and CCK-monoamine interactions in the control of satiety. Am J Clin Nutr 55: 291S-295S, 1992.[Abstract/Free Full Text]
  8. Covasa M and Ritter RC. Adaptation to high-fat diet reduces inhibition of gastric emptying by CCK and intestinal oleate. Am J Physiol Regul Integr Comp Physiol 278: R166–R170, 2000.[Abstract/Free Full Text]
  9. Covasa M and Ritter RC. Attenuated satiation response to intestinal nutrients in rats that do not express CCK-A receptors. Peptides 22: 1339–1348, 2001.[CrossRef][ISI][Medline]
  10. Covasa M, Ritter RC, and Burns GA. NMDA receptor participation in control of food intake by the stomach. Am J Physiol Regul Integr Comp Physiol 278: R1362–R1368, 2000.[Abstract/Free Full Text]
  11. Daughters RS, Hofbauer RD, Grossman AW, Marshall AM, Brown EM, Hartman BK, and Faris PL. Ondansetron attenuates CCK induced satiety and c-fos labeling in the dorsal medulla. Peptides 22: 1331–1338, 2001.[CrossRef][ISI][Medline]
  12. Davis JD, Smith GP, and Sayler JL. Closing the pylorus decreases the size of large meals in the rat. Physiol Behav 63: 191–196, 1998.[CrossRef][Medline]
  13. De Jonghe BC, Hajnal A, and Covasa M. Increased food intake in CCK-1 receptor deficient OLETF rats increase intake but not gastric emptying of solid and liquid meals (Abstract). Appetite 44, 2005.
  14. Doucet E, Miquel MC, Nosjean A, Verge D, Hamon M, and Emerit MB. Immunolabeling of the rat central nervous system with antibodies partially selective of the short form of the 5-HT3 receptor. Neuroscience 95: 881–892, 2000.[CrossRef][ISI][Medline]
  15. Fujimiya M, Okumiya K, and Kuwahara A. Immunoelectron microscopic study of the luminal release of serotonin from rat enterochromaffin cells induced by high intraluminal pressure. Histochem Cell Biol 108: 105–113, 1997.[CrossRef][ISI][Medline]
  16. Gershon MD. Roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther 13, Suppl 2: 15–30, 1999.[CrossRef][ISI][Medline]
  17. Gibbs J, Maddison SP, and Rolls ET. Satiety role of the small intestine examined in sham-feeding rhesus monkeys. J Comp Physiol Psychol 95: 1003–1015, 1981.[CrossRef][ISI][Medline]
  18. Glatzle J, Sternini C, Robin C, Zittel TT, Wong H, Reeve JR Jr, and Raybould HE. Expression of 5-HT3 receptors in the rat gastrointestinal tract. Gastroenterology 123: 217–226, 2002.[CrossRef][ISI][Medline]
  19. Hayes MR and Covasa M. CCK and 5-HT act synergistically to suppress food intake through simultaneous activation of CCK-1 and 5-HT3 receptors. Peptides 26: 2322–2330, 2005.[CrossRef][ISI][Medline]
  20. Hayes MR and Covasa M. Hindbrain administration of 5-HT3 receptor antagonist, ondansetron attenuates systemic CCK-induced satiation (Abstract). Appetite 44, 2005.
  21. Hayes MR, Moore RL, Shah SM, and Covasa M. 5-HT3 receptors participate in CCK-induced suppression of food intake by delaying gastric emptying. Am J Physiol Regul Integr Comp Physiol 287: R817–R823, 2004.[Abstract/Free Full Text]
  22. Hayes MR, Savastano DM, and Covasa M. Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors. Physiol Behav 82: 663–669, 2004.[CrossRef][Medline]
  23. Horn CC, Richardson EJ, Andrews PL, and Friedman MI. Differential effects on gastrointestinal and hepatic vagal afferent fibers in the rat by the anti-cancer agent cisplatin. Auton Neurosci 115: 74–81, 2004.[CrossRef][ISI][Medline]
  24. Kalogeris TJ, Reidelberger RD, and Mendel VE. Effect of nutrient density and composition of liquid meals on gastric emptying in feeding rats. Am J Physiol Regul Integr Comp Physiol 244: R865–R871, 1983.[Abstract/Free Full Text]
  25. Kaplan JM, Spector AC, and Grill HJ. Dynamics of gastric emptying during and after stomach fill. Am J Physiol Regul Integr Comp Physiol 263: R813–R819, 1992.[Abstract/Free Full Text]
  26. Kissileff HR, Carretta JC, Geliebter A, and Pi-Sunyer FX. Cholecystokinin and stomach distension combine to reduce food intake in humans. Am J Physiol Regul Integr Comp Physiol 285: R992–R998, 2003.[Abstract/Free Full Text]
  27. Laporte AM, Koscielniak T, Ponchant M, Verge D, Hamon M, and Gozlan H. Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands. Synapse 10: 271–281, 1992.[CrossRef][ISI][Medline]
  28. Lau AH, Kan KK, Lai HW, Ngan MP, Rudd JA, Wai MK, and Yew DT. Action of ondansetron and CP-99,994 to modify behavior and antagonize cisplatin-induced emesis in the ferret. Eur J Pharmacol 506: 241–247, 2005.[CrossRef][ISI][Medline]
  29. Li Y, Hao Y, Zhu J, and Owyang C. Serotonin released from intestinal enterochromaffin cells mediates luminal non-cholecystokinin-stimulated pancreatic secretion in rats. Gastroenterology 118: 1197–1207, 2000.[CrossRef][ISI][Medline]
  30. Li Y, Wu X, and Owyang C. Serotonin and cholecystokinin synergistically stimulate rat vagal primary afferent neurons. J Physiol 559: 651–662, 2004.[Abstract/Free Full Text]
  31. Lutz TA, Tschudy S, Rushing PA, and Scharrer E. Attenuation of the anorectic effects of cholecystokinin and bombesin by the specific amylin antagonist AC 253. Physiol Behav 70: 533–536, 2000.[CrossRef][Medline]
  32. Matson CA, Wiater MF, Kuijper JL, and Weigle DS. Synergy between leptin and cholecystokinin (CCK) to control daily caloric intake. Peptides 18: 1275–1278, 1997.[CrossRef][ISI][Medline]
  33. Mazda T, Yamamoto H, Fujimura M, and Fujimiya M. Gastric distension-induced release of serotonin stimulates c-fos expression in specific brain nuclei via 5-HT3 receptors in conscious rats. Am J Physiol Gastrointest Liver Physiol 287: G228–G235, 2004.[Abstract/Free Full Text]
  34. McHugh PR, Moran TH, and Wirth JB. Postpyloric regulation of gastric emptying in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol 243: R408–R415, 1982.[Abstract/Free Full Text]
  35. Meyer BM, Werth BA, Beglinger C, Hildebrand P, Jansen JB, Zach D, Rovati LC, and Stalder GA. Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 2: 12–15, 1989.[CrossRef][ISI][Medline]
  36. Moran TH, Baldessarini AR, Salorio CF, Lowery T, and Schwartz GJ. Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin. Am J Physiol Regul Integr Comp Physiol 272: R1245–R1251, 1997.[Abstract/Free Full Text]
  37. Moran TH and McHugh PR. Cholecystokinin suppresses food intake by inhibiting gastric emptying. Am J Physiol Regul Integr Comp Physiol 242: R491–R497, 1982.[Abstract/Free Full Text]
  38. Muurahainen NE, Kissileff HR, Lachaussee J, and Pi-Sunyer FX. Effect of a soup preload on reduction of food intake by cholecystokinin in humans. Am J Physiol Regul Integr Comp Physiol 260: R672–R680, 1991.[Abstract/Free Full Text]
  39. Oldendorf WH. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol 221: 1629–1639, 1971.[Free Full Text]
  40. Phillips RJ and Powley TL. Gastric volume detection after selective vagotomies in rats. Am J Physiol Regul Integr Comp Physiol 274: R1626–R1638, 1998.[Abstract/Free Full Text]
  41. Phillips RJ and Powley TL. Gastric volume rather than nutrient content inhibits food intake. Am J Physiol Regul Integr Comp Physiol 271: R766–R769, 1996.[Abstract/Free Full Text]
  42. Powley TL and Phillips RJ. Gastric satiation is volumetric, intestinal satiation is nutritive. Physiol Behav 82: 69–74, 2004.[CrossRef][Medline]
  43. Pratt GD and Bowery NG. The 5-HT3 receptor ligand, [3H]BRL 43694, binds to presynaptic sites in the nucleus tractus solitarius of the rat. Neuropharmacology 28: 1367–1376, 1989.[CrossRef][ISI][Medline]
  44. Raybould HE, Glatzle J, Robin C, Meyer JH, Phan T, Wong H, and Sternini C. Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying. Am J Physiol Gastrointest Liver Physiol 284: G367–G372, 2003.[Abstract/Free Full Text]
  45. Raybould HE and Tache Y. Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats. Am J Physiol Gastrointest Liver Physiol 255: G242–G246, 1988.[Abstract/Free Full Text]
  46. Ritter RC. Gastrointestinal mechanisms of satiation for food. Physiol Behav 81: 249–273, 2004.[CrossRef][Medline]
  47. Ritter RC, Covasa M, Matson CA. Cholecystokinin: proofs and prospects for involvement in control of food intake and body weight. Neuropeptides 33: 387–399, 1999.[CrossRef][ISI][Medline]
  48. Savastano DM, Carelle M, and Covasa M. Serotonin-type 3 receptors mediate intestinal polycose- and glucose-induced suppression of intake. Am J Physiol Regul Integr Comp Physiol 288: R1499–R1508, 2005.[Abstract/Free Full Text]
  49. Savastano DM, Hayes MR, and Covasa M. Differential effects of 5HT3 receptor blockade in nutrient-induced satiation (Abstract). Abstr Soc Neurosci, 2003.
  50. Schwartz GJ, McHugh PR, and Moran TH. Gastric loads and cholecystokinin synergistically stimulate rat gastric vagal afferents. Am J Physiol Regul Integr Comp Physiol 265: R872–R876, 1993.[Abstract/Free Full Text]
  51. Schwartz GJ, Netterville LA, McHugh PR, and Moran TH. Gastric loads potentiate inhibition of food intake produced by a cholecystokinin analogue. Am J Physiol Regul Integr Comp Physiol 261: R1141–R1146, 1991.[Abstract/Free Full Text]
  52. Seeley RJ, Kaplan JM, and Grill HJ. Effect of occluding the pylorus on intraoral intake: a test of the gastric hypothesis of meal termination. Physiol Behav 58: 245–249, 1995.[CrossRef][Medline]
  53. Simpson KH, Murphy P, Colthup PV, and Whelan P. Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers. Psychopharmacology (Berl) 109: 497–498, 1992.[CrossRef][Medline]
  54. Traub RJ, Sengupta JN, and Gebhart GF. Differential c-fos expression in the nucleus of the solitary tract and spinal cord following noxious gastric distention in the rat. Neuroscience 74: 873–884, 1996.[CrossRef][ISI][Medline]
  55. van de Wall EH, Duffy P, and Ritter RC. CCK enhances response to gastric distension by acting on capsaicin insensitive vagal afferents. Am J Physiol Regul Integr Comp Physiol 289: R695–R703, 2005.[Abstract/Free Full Text]
  56. Wang Y, Ramage AG, and Jordan D. In vivo effects of 5-hydroxytryptamine receptor activation on rat nucleus tractus solitarius neurones excited by vagal C-fibre afferents. Neuropharmacology 36: 489–498, 1997.[CrossRef][ISI][Medline]
  57. Yoshida-Yoneda E, O-Lee TJ, Wei JY, Vigna SR, and Tache Y. Peripheral bombesin induces gastric vagal afferent activation in rats. Am J Physiol Regul Integr Comp Physiol 271: R1584–R1593, 1996.[Abstract/Free Full Text]
  58. Young WG and Deutsch JA. The construction, surgical implantation, and use of gastric catheters and a pyloric cuff. J Neurosci Methods 3: 377–384, 1981.[CrossRef][ISI][Medline]
  59. Yox DP, Brenner L, and Ritter RC. CCK-receptor antagonists attenuate suppression of sham feeding by intestinal nutrients. Am J Physiol Regul Integr Comp Physiol 262: R554–R561, 1992.[Abstract/Free Full Text]
  60. Yox DP and Ritter RC. Capsaicin attenuates suppression of sham feeding induced by intestinal nutrients. Am J Physiol Regul Integr Comp Physiol 255: R569–R574, 1988.[Abstract/Free Full Text]
  61. Yu PL, Fujimura M, Hayashi N, Nakamura T, and Fujimiya M. Mechanisms in regulating the release of serotonin from the perfused rat stomach. Am J Physiol Gastrointest Liver Physiol 280: G1099–G1105, 2001.[Abstract/Free Full Text]
  62. Zhu JX, Zhu XY, Owyang C, and Li Y. Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat. J Physiol 530: 431–442, 2001.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. M. Savastano, M. R. Hayes, and M. Covasa
Serotonin-type 3 receptors mediate intestinal lipid-induced satiation and Fos-like immunoreactivity in the dorsal hindbrain
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1063 - R1070.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. Tome
From gut nutrient sensing to nutrient perception: a cooperative role involving CCK and 5-HT?
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1061 - R1062.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Aja
Serotonin-3 receptors in gastric mechanisms of cholecystokinin-induced satiety
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R112 - R114.
[Full Text] [PDF]